Copyright: ©Author(s) 2026.
World J Diabetes. Jun 15, 2026; 17(6): 118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Figure 3 Effect of Tangwang formula on the body weight and blood glucose in diabetic retinopathy mice (n = 10).
A: Schematic representation of animal study design; B: Changes in body weight per week; C: Statistical analysis of body weight on the 18th week; D: Changes in random blood glucose per week; E: Statistical analysis of random blood glucose on the 18th week. The data are expressed as mean ± SD, bP < 0.01 vs control group, cP < 0.05 vs model group, and dP < 0.01 vs model group. CaD: Calcium dobesilate; Glu: Glucose; STZ: Streptozotocin; TWF: Tangwang formula.
- Citation: Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; 17(6): 118650
- URL: https://www.wjgnet.com/1948-9358/full/v17/i6/118650.htm
- DOI: https://dx.doi.org/10.4239/wjd.118650